UMIN ID: C000000112
Registered date:04/09/2005
Phase II study of carboplatin-gemcitabine combination chemotherapy in elderly patients with advanced non–small cell lung cancer
Basic Information
| Recruitment status | |
|---|---|
| Health condition(s) or Problem(s) studied | non small cell lung cancer |
| Date of first enrollment | 2004/10/01 |
| Target sample size | 55 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | day 1: CBDCA 4AUC GEM 1000mg/m2 day 8: GEM 1000mg/m2 |
Outcome(s)
| Primary Outcome | response rate |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 70years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Individuals with active infection, severe heart disease, active concomitant malignancy, or pleural or pericardial effusion requiring drainage were excluded. |
Related Information
| Primary Sponsor | Kumamoto University School of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Kumamoto University School of Medicine |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Ji-ichiro Sasaki |
| Address | Japan |
| Telephone | |
| saji@gpo.kumamoto-u.ac.jp | |
| Affiliation | Kumamoto University School of Medicine Department of Respiratory Medicine |
| scientific contact | |
| Name | Isamu Okamoto |
| Address | 377-2 Ohno-higashi, Osaka-Sayama, Japan |
| Telephone | |
| Affiliation | Kinki University School of Medicine Department of Medical Oncology, |